45 CFR § 180 compliance
D · 65
This hospital published part of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
○Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
22,526
Insurances with rates
21
CPT / HCPCS codes
3,577
Source MRF
Most expensive procedures (gross)
00078080461
$671,912
SandoSTATIN LAR Depot
Gross
$1,119,853
59572050300
$369,849
Pomalyst
Gross
$616,416
59572050100
$369,849
Pomalyst
Gross
$616,416
59572050400
$369,849
Pomalyst
Gross
$616,416
59572050200
$369,849
Pomalyst
Gross
$616,416
25682-0028-01
$228,250
Ultomiris
Gross
$380,416
00006306101
$162,643
Emend
Gross
$271,072
67457088910
$146,216
fosaprepitant dimeglumine
Gross
$243,694
71839010401
$146,216
fosaprepitant dimeglumine
Gross
$243,694
24338005008
$136,869
Gliadel
Gross
$228,115
00310453530
$134,105
Imjudo
Gross
$223,509
00310-4535-30
$126,371
Imjudo
Gross
$210,619
60505267708
$122,618
ARIPiprazole
Gross
$204,364
00003232822
$117,360
Yervoy
Gross
$195,601
73150-0150-06
$101,804
Briumvi
Gross
$169,673
75987008010
$99,619
Krystexxa
Gross
$166,031
66215060214
$96,706
Uptravi
Gross
$161,176
57894006103
$94,462
Stelara PFS
Gross
$157,437
C1787
$90,720
PATIENT PROGRAMMER; NEUROSTIMULATOR
Gross
$151,200
59572041028
$80,893
Revlimid
Gross
$134,821
00187552675
$80,605
Targretin
Gross
$134,341
00006508399
$77,974
Keytruda Qlex
Gross
$129,957
00006508301
$77,974
Keytruda Qlex
Gross
$129,957
59572050421
$77,677
Pomalyst
Gross
$129,462
25682002801
$77,612
Ultomiris
Gross
$129,354
00069814020
$77,036
Xalkori
Gross
$128,393
00069814120
$77,036
Xalkori
Gross
$128,393
C1767
$76,545
GENERATOR; NEUROSTIMULATOR (IMPLANTABLE); NON-RECHARGEABLE
Gross
$127,575
69488001061
$74,517
Pluvicto
Gross
$124,195
00069098038
$72,845
Sutent
Gross
$121,408
24338015020
$72,256
Triptodur
Gross
$120,426
J3316
$72,256
INJ., TRIPTORELIN XR 3.75 MG
Gross
$120,426
50242015001
$70,366
Ocrevus
Gross
$117,276
00069013501
$69,658
Bosulif
Gross
$116,096
00069013601
$69,657
Bosulif
Gross
$116,096
00078068715
$68,845
Promacta
Gross
$114,741
00069014501
$68,576
Inlyta
Gross
$114,294
00069015111
$68,576
Inlyta
Gross
$114,294
13668068212
$68,319
SORAfenib tosylate
Gross
$113,864
24979071544
$68,319
SORAfenib tosylate
Gross
$113,864
00003052811
$65,613
Sprycel
Gross
$109,355
00003052411
$65,613
Sprycel
Gross
$109,355
76346007301
$65,586
Korlym
Gross
$109,310
76128015575
$62,983
Photofrin
Gross
$104,972
60505363006
$62,333
dasatinib
Gross
$103,888
66993023460
$62,333
dasatinib
Gross
$103,888
66993023560
$62,333
dasatinib
Gross
$103,888
60505362906
$62,333
dasatinib
Gross
$103,888
00078062051
$62,009
Afinitor
Gross
$103,349
00078056751
$62,009
Afinitor
Gross
$103,349
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| 00078080461 | SandoSTATIN LAR Depot | $1,119,853 | $671,912 | — | — | 12 |
| 59572050300 | Pomalyst | $616,416 | $369,849 | — | — | 0 |
| 59572050100 | Pomalyst | $616,416 | $369,849 | — | — | 0 |
| 59572050400 | Pomalyst | $616,416 | $369,849 | — | — | 0 |
| 59572050200 | Pomalyst | $616,416 | $369,849 | — | — | 0 |
| 25682-0028-01 | Ultomiris | $380,416 | $228,250 | — | — | 11 |
| 00006306101 | Emend | $271,072 | $162,643 | — | — | 1 |
| 67457088910 | fosaprepitant dimeglumine | $243,694 | $146,216 | — | — | 1 |
| 71839010401 | fosaprepitant dimeglumine | $243,694 | $146,216 | — | — | 1 |
| 24338005008 | Gliadel | $228,115 | $136,869 | — | — | 0 |
| 00310453530 | Imjudo | $223,509 | $134,105 | — | — | 12 |
| 00310-4535-30 | Imjudo | $210,619 | $126,371 | — | — | 12 |
| 60505267708 | ARIPiprazole | $204,364 | $122,618 | — | — | 0 |
| 00003232822 | Yervoy | $195,601 | $117,360 | — | — | 12 |
| 73150-0150-06 | Briumvi | $169,673 | $101,804 | — | — | 11 |
| 75987008010 | Krystexxa | $166,031 | $99,619 | — | — | 12 |
| 66215060214 | Uptravi | $161,176 | $96,706 | — | — | 0 |
| 57894006103 | Stelara PFS | $157,437 | $94,462 | — | — | 1 |
| C1787 | PATIENT PROGRAMMER; NEUROSTIMULATOR | $151,200 | $90,720 | — | — | 0 |
| 59572041028 | Revlimid | $134,821 | $80,893 | — | — | 0 |
| 00187552675 | Targretin | $134,341 | $80,605 | — | — | 0 |
| 00006508399 | Keytruda Qlex | $129,957 | $77,974 | — | — | 0 |
| 00006508301 | Keytruda Qlex | $129,957 | $77,974 | — | — | 0 |
| 59572050421 | Pomalyst | $129,462 | $77,677 | — | — | 0 |
| 25682002801 | Ultomiris | $129,354 | $77,612 | — | — | 12 |
| 00069814020 | Xalkori | $128,393 | $77,036 | — | — | 0 |
| 00069814120 | Xalkori | $128,393 | $77,036 | — | — | 0 |
| C1767 | GENERATOR; NEUROSTIMULATOR (IMPLANTABLE); NON-RECHARGEABLE | $127,575 | $76,545 | — | — | 0 |
| 69488001061 | Pluvicto | $124,195 | $74,517 | — | — | 12 |
| 00069098038 | Sutent | $121,408 | $72,845 | — | — | 0 |
| 24338015020 | Triptodur | $120,426 | $72,256 | — | — | 12 |
| J3316 | INJ., TRIPTORELIN XR 3.75 MG | $120,426 | $72,256 | — | — | 12 |
| 50242015001 | Ocrevus | $117,276 | $70,366 | — | — | 12 |
| 00069013501 | Bosulif | $116,096 | $69,658 | — | — | 0 |
| 00069013601 | Bosulif | $116,096 | $69,657 | — | — | 0 |
| 00078068715 | Promacta | $114,741 | $68,845 | — | — | 0 |
| 00069014501 | Inlyta | $114,294 | $68,576 | — | — | 0 |
| 00069015111 | Inlyta | $114,294 | $68,576 | — | — | 0 |
| 13668068212 | SORAfenib tosylate | $113,864 | $68,319 | — | — | 0 |
| 24979071544 | SORAfenib tosylate | $113,864 | $68,319 | — | — | 0 |
| 00003052811 | Sprycel | $109,355 | $65,613 | — | — | 0 |
| 00003052411 | Sprycel | $109,355 | $65,613 | — | — | 0 |
| 76346007301 | Korlym | $109,310 | $65,586 | — | — | 0 |
| 76128015575 | Photofrin | $104,972 | $62,983 | — | — | 1 |
| 60505363006 | dasatinib | $103,888 | $62,333 | — | — | 0 |
| 66993023460 | dasatinib | $103,888 | $62,333 | — | — | 0 |
| 66993023560 | dasatinib | $103,888 | $62,333 | — | — | 0 |
| 60505362906 | dasatinib | $103,888 | $62,333 | — | — | 0 |
| 00078062051 | Afinitor | $103,349 | $62,009 | — | — | 0 |
| 00078056751 | Afinitor | $103,349 | $62,009 | — | — | 0 |
Showing top 50 of 22,526 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.